Lamia Ammari
Badreddine Kilani
Hanène Tiouiri
Fakher Kanoun
Ahmed Goubontini
Emna Mnif
Fayçal Zouiten
Emna Chaker
Taoufik Ben Chaabane


Introduction : Mucormycosis is a rare and invasive fungal infection, but frequently fatal when it occurs. It commonly affects patients with diabetes mellitus. The aim of this study is to assess the clinical presentation, radiological findings, management and prognosis of mucormycosis.
Methods : this retrospective study was conducted in the department of infectious diseases of Rabta hospital between January 1988 and December 2004 and included patients hospitalized for mucormycosis confirmed by mycological and/or histological findings.
Results : the study is about four diabetic patients with mucormycosis (3 men and a woman). Three of them had diabetic ketoacidosis at the time of diagnosis. The infection was sinusal in 2 cases and rhinocerebral in the the other two cases. Treatment consisted in systemic amphotericin B combined with surgical debridement in 3 cases. A fatal outcome was noted in 2 cases.
Conclusion : Mucormycosis remains a severe infectious disease in diabetic patients. Early diagnosis and treatment is mandatory for a successful management of this infection.


Mucormycosis, diabetes mellitus, Rhizopus, therapy



  1. Berrylin J, Ferguson Md. Mucormycosis of the nose and paranasal sinuses. Otolaryngologic clinics of North America 2000 ; 33 : 349-65
  2. Alan Ms. Mucormycosis. Clin.Infect.Diseases 1992 ; 14(suppl):126-9.
  3. Prabhu Rm, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin.Microbiol.Infect. 2004 ; 10(suppl) : 31-47.
  4. Livio P, Paolo R, Anna T, et al. Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. Br.J.of Haematology 1997; 99: 331-36.
  5. Nollaig A, Parferey Mb. Improved and prognosis of mucormycosis ( Aclinicopathologic study of 33 cases). Medecine 1986 ; 65 : 113-23.
  6. Warwar Re, Bullock Jd. Rhino-orbital-cerebral mucormycosis: a review. Orbit 1998; 17 : 237-45.
  7. Gayet Delacroix M, Dupas B, Legent F, Beauvillain C. Sinusites fongiques et granulomatoses. Imagerie maxillo-faciale. 4ème ed. Flammarion et Cie, 1997.
  8. Dannaoui E, Meletiadis J, Mouton Jw, Meis Jm, Verweij PE. In vitro susceptibilities of zygomycetes to conventionnal and new antifungals. J. Antimicrobial Chemotherapy 2003 ; 51 : 45-52.
  9. Greenberg Rn, Scott Lj, Vaughn Hh, Ribes Ja. Zygomycosis (mucormycosis): emerging clinical importance and new treatments. Current Opinion in Infect.Dis 2004 ; 17 : 517-25.
  10. Kok J, Gilroy N, Halliday C, et al. Early use of posaconazole in the successful treatment of rhino-orbital mucormycosis caused by Rhizopus oryzae. Journal of Infection 2007 ; 55 : 33-36.